News
Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.
A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against treatment-resistant depression, giving biotechs hope that this type of drug will become ...
A team of Ohio State researchers engineered a new antibody that could revolutionize influenza prevention through a nasal spray.
I use two brands of nasal spray for congestion, but both say not to use them for more than three days as they may cause “rebound” congestion. Can I alternate them for six days or three days each?
One of the most concerning side effects of overusing nasal sprays is a condition known as rebound congestion, or rhinitis medicamentosa (RM). This occurs when the nose becomes reliant on the spray ...
University of Florida researchers now believe they have discovered an idea that might ultimately lead to an effective treatment for the inflammation-related loss of the sense of smell.
“I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla said in a viral TikTok.
Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine.
This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing school nurses to give epinephrine uses the phrase "auto-injectors" when ...
Milestone Pharmaceuticals reports upcoming FDA review for CARDAMYST™ nasal spray targeting PSVT, pending approval by March 2025.
A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in ...
More than 89,000 NasoGel nasal sprays are being recalled by NeilMed over concerns of a microbial failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results